Phase 2 Multicenter Trial Evaluating the Role of Induction TPF Followed by Weekly Docetaxel and Cetuximab in Combination With IMRT for Locally Recurrent Nasopharyngeal Carcinoma
Ng, W.T.; Ngan, R.K.C.; Lee, A.W.M.; Kwong, D.L.W.; Tung, S.Y.; Yuen, K.; Kam, K.M.M.; Chan, L.; Li-Lung, M.
International Journal of Radiation Oncology*biology*physics 99(2): E351-E352
2017
ISSN/ISBN: 0360-3016
DOI: 10.1016/j.ijrobp.2017.06.1441
Accession: 065033147
PDF emailed within 0-6 h: $19.90
Related References
Ngan, R.K.; Ng, W.T.; Kwong, D.; Tung, S.; Yau, C.C.; Leung, S.F.; Chan, W.Y.; Lung, M.; Lee, A. 2015: 334Ppreliminary results of Hknpc-1001 trial to evaluate the role of induction Tpf followed by weekly docetaxel and cetuximab in combination with intensity modulated radiotherapy for locally recurrent nasopharyngeal carcinoma Annals of Oncology 26(Suppl 9): ix 98.4-ix 99Xu, T.; Liu, Y.; Dou, S.; Li, F.; Guan, X.; Zhu, G. 2015: Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase Ii study Oral Oncology 51(9): 875-879
Ng, W.-T.; Ngan, R.K.C.; Kwong, D.L.W.; Tung, S.Y.; Yuen, K.-T.; Kam, M.K.M.; Sze, H.C.K.; Yiu, H.H.Y.; Chan, L.L.K.; Lung, M.L.; Lee, A.W.M. 2018: Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma International Journal of Radiation Oncology Biology Physics 100(3): 630-638
Johnson-Buarque, E.J. 2016: Phase I/II trial of induction chemotherapy in locally advanced head and neck carcinoma (LAHNC) and recurrent disease (RD) after surgery/radiotherapy with weekly docetaxel (D), tomudex (T) and cisplatin (P)-DTP Journal of Clinical Oncology 24(18_Suppl): 15536-15536
Zhang, X.; Du, L.; Zhao, F.; Wang, Q.; Yang, S.; Ma, L. 2016: A Phase II Clinical Trial of Concurrent Helical Tomotherapy plus Cetuximab Followed by Adjuvant Chemotherapy with Cisplatin and Docetaxel for Locally Advanced Nasopharyngeal Carcinoma International Journal of Biological Sciences 12(4): 446-453
Chan, A.T.C.; Hsu, M.-M.; Goh, B.C.; Hui, E.P.; Liu, T.-W.; Millward, M.J.; Hong, R.-L.; Whang-Peng, J.; Ma, B.B.Y.; To, K.F.; Mueser, M.; Amellal, N.; Lin, X.; Chang, A.Y. 2005: Multicenter, phase Ii study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(15): 3568-3576
Zhang, J.; Lee, J.; Urba, S.; Foster, J.; Worden, F. 2010: A phase Ii trial evaluating weekly docetaxel and capecitabine in patients with metastatic or advanced, locally recurrent head and neck cancers Cancer Investigation 28(9): 910-916
Yamouni, M.; Beldjillali, Y.; Lahfa, I.; Benhadji, K.A.; Larbaoui, B.; Brahimi, M.; Ait Said, M.; Djellali, L.; Bouzid, K. 2003: Phase II trial of Docetaxel and Cisplatin combination in locally advanced undifferentiated carcinoma of nasopharyngeal type EJC Suppls 1(5): S45
2016: (S007) Results of a Phase II Trial Using Cetuximab Plus Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma Oncology 30 Suppl
Ruhstaller, T.; Pless, M.; Dietrich, D.; Kranzbuehler, H.; von Moos, R.; Moosmann, P.; Montemurro, M.; Schneider, P.M.; Rauch, D.; Gautschi, O.; Mingrone, W.; Widmer, L.; Inauen, R.; Brauchli, P.; Hess, V. 2011: Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/Ii Trial (SAKK 75/06) Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 29(6): 626-631
Yamouni, M.; Benhadji, K.A.; Beldjilali, Y.; Lahfa, I.; Yekrou, D.; Djellali, L.; Brahimi, M.; Bouzid, K. 2016: A phase II trial of docetaxel and cisplatin combination in patients with locally advanced undifferentiated carcinoma of nasopharyngeal type (UCNT): Study update Journal of Clinical Oncology 24(18_Suppl): 5579-5579
Kong, L.; Hu, J.; Guan, X.; Gao, J.; Lu, R.; Lu, J.J. 2016: Phase I/Ii Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma Journal of Cancer 7(7): 774-783
Ruhstaller, T.; Widmer, L.; Schuller, J.C.; Roth, A.; Hess, V.; Mingrone, W.; von Moos, R.; Borner, M.; Pestalozzi, B.C.; BalmerMajno, S.; Köberle, D.; Terraciano, L.; Schnider, A.; Bodis, S.; Popescu, R. 2009: Multicenter phase Ii trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02) Annals of Oncology: Official Journal of the European Society for Medical Oncology 20(9): 1522-1528
Kong, L.; Gao, J.; Hu, J.; Hu, W.; Guan, X.; Lu, R.; Lu, J.J. 2016: Phase I/Ii trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma Chinese Journal of Cancer 35(1): 101
Rochlitz, C.; Ruhstaller, T.; Lerch, S.; Spirig, C.; Huober, J.; Suter, T.; Bühlmann, M.; Fehr, M.; Schönenberger, A.; von Moos, R.; Winterhalder, R.; Rauch, D.; Müller, A.; Mannhart-Harms, M.; Herrmann, R.; Cliffe, B.; Mayer, M.; Zaman, K. 2011: Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. a multicenter, single-arm phase Ii trial (SAKK 24/06) Annals of Oncology: Official Journal of the European Society for Medical Oncology 22(1): 80-85